Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates.
about
Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro.AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogensRole of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus.Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDSAIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.Feline immunodeficiency virus neuropathogenesis: from cats to calcium.AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccineAIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies.Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.
P2860
Q33641801-4164DFFD-A885-4F84-9C68-1010ADC225C7Q33840406-C3354B53-8865-4F8F-BD27-9302CE1C5354Q33854938-E45B01BE-2EAF-427E-8610-5261B6DCEE9AQ35024266-924209FE-3998-420B-9ADC-752D3386078EQ36099050-4491E2B0-82F4-4051-9AFD-FB6828329212Q36462709-F8E98655-DF92-4D05-AD40-71224813845BQ36473694-79409596-03AA-4C18-B414-2FF1C0BF819BQ37015529-8A6C3F03-8E39-4FF6-8EFC-AA3F44C64350Q39548535-2AADF88A-D74E-47A5-B377-45F6E3ED4B03Q39602555-9620168C-463D-4BF0-9029-9C0DA986C736Q39732473-27622829-87E5-424A-B5C5-7104050AC872
P2860
Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Autologous and heterologous ne ...... munodeficiency virus isolates.
@en
Autologous and heterologous ne ...... munodeficiency virus isolates.
@nl
type
label
Autologous and heterologous ne ...... munodeficiency virus isolates.
@en
Autologous and heterologous ne ...... munodeficiency virus isolates.
@nl
prefLabel
Autologous and heterologous ne ...... munodeficiency virus isolates.
@en
Autologous and heterologous ne ...... munodeficiency virus isolates.
@nl
P2093
P2860
P1433
P1476
Autologous and heterologous ne ...... munodeficiency virus isolates.
@en
P2093
D Del Mauro
D Matteucci
M Bendinelli
M Pistello
S Giannecchini
P2860
P304
P407
P577
1998-03-01T00:00:00Z